Purple Biotech (PPBT) Change in Intangibles (2022)

Purple Biotech (PPBT) reported Change in Intangibles of $1000.0 for Q3 2022, up 100.49% quarter-over-quarter from -$203000.0 in Q1 2022.

Purple Biotech (PPBT) Change in Intangibles (2022) Analysis & Trends

Purple Biotech (PPBT) has 1 years of Change in Intangibles data on file, last reported at $1000.0 in Q3 2022.

Change in Intangibles for Q3 2022 came in at $1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was -$202000.0 (changed N/A YoY), and the FY2022 annual result was -$202000.0, changed N/A from the prior year.
Change in Intangibles advanced to $1000.0 in Q3 2022 per PPBT's latest filing, from -$203000.0 in the prior quarter.
Over five years, Change in Intangibles peaked at $1000.0 in Q3 2022 and troughed at -$203000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-2.96 Mn
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Purple Biotech	242.86 Mn	236.43 Mn	-	-

Download Data